influenza virus vaccine
FDA Drug Profile — FLUARIX 2025/2026, FLULAVAL 2025/2026
Drug Details
- Generic Name
- influenza virus vaccine
- Brand Names
- FLUARIX 2025/2026, FLULAVAL 2025/2026
- Application Number
- BLA125127
- Sponsor
- GlaxoSmithKline Biologicals SA
- NDC Codes
- 2
- Dosage Forms
- SUSPENSION
- Routes
- INTRAMUSCULAR
- Active Ingredients
- INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)